BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
8.26
+0.09 (1.10%)
Aug 6, 2025, 12:13 PM EDT
BioSyent Market Cap
BioSyent has a market cap or net worth of $95.30 million as of August 7, 2025. Its market cap has increased by 12.10% in one year.
Market Cap
95.30M
Enterprise Value
83.39M
Revenue
26.63M
Ranking
n/a
PE Ratio
17.51
Stock Price
$8.26
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 95.30M, an increase of 905.13%. That is a compound annual growth rate of 8.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 95.30M | 7.38% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |